BICO Stock Overview
Operates as a bioconvergence company in North America, Europe, Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
BICO Group AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 32.34 |
| 52 Week High | SEK 62.62 |
| 52 Week Low | SEK 29.32 |
| Beta | 2.38 |
| 1 Month Change | -11.15% |
| 3 Month Change | -23.26% |
| 1 Year Change | -46.05% |
| 3 Year Change | -88.87% |
| 5 Year Change | -61.95% |
| Change since IPO | 137.36% |
Recent News & Updates
Recent updates
Here's Why BICO Group (STO:BICO) Can Afford Some Debt
Jul 01
The Market Doesn't Like What It Sees From BICO Group AB (publ)'s (STO:BICO) Earnings Yet As Shares Tumble 26%
Jun 08Why BICO Group AB (publ) (STO:BICO) Could Be Worth Watching
Dec 02Calculating The Fair Value Of BICO Group AB (publ) (STO:BICO)
May 20Is BICO Group AB (publ) (STO:BICO) Potentially Undervalued?
May 04Is BICO Group (STO:BICO) Using Too Much Debt?
Feb 09Health Check: How Prudently Does BICO Group (STO:BICO) Use Debt?
Oct 24Shareholder Returns
| BICO | SE Life Sciences | SE Market | |
|---|---|---|---|
| 7D | -3.5% | -1.6% | -2.7% |
| 1Y | -46.0% | 16.5% | 4.6% |
Return vs Industry: BICO underperformed the Swedish Life Sciences industry which returned 16.5% over the past year.
Return vs Market: BICO underperformed the Swedish Market which returned 4.6% over the past year.
Price Volatility
| BICO volatility | |
|---|---|
| BICO Average Weekly Movement | 9.2% |
| Life Sciences Industry Average Movement | 7.6% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.3% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: BICO's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: BICO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 824 | Maria Forss | www.bico.com |
BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing.
BICO Group AB (publ) Fundamentals Summary
| BICO fundamental statistics | |
|---|---|
| Market cap | SEK 2.28b |
| Earnings (TTM) | -SEK 1.70b |
| Revenue (TTM) | SEK 2.33b |
1.0x
P/S Ratio-1.3x
P/E RatioIs BICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BICO income statement (TTM) | |
|---|---|
| Revenue | SEK 2.33b |
| Cost of Revenue | SEK 639.40m |
| Gross Profit | SEK 1.69b |
| Other Expenses | SEK 3.40b |
| Earnings | -SEK 1.70b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 19, 2025
| Earnings per share (EPS) | -24.14 |
| Gross Margin | 72.57% |
| Net Profit Margin | -73.09% |
| Debt/Equity Ratio | 52.8% |
How did BICO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:11 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BICO Group AB (publ) is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dylan van Haaften | Bryan Garnier & Co |
| Hanseung Yoo | Bryan Garnier & Co |
| Maria Vara Fernández | Bryan Garnier & Co |